Vaccines for Immune Mediated Diseases

 Patients with immune-mediated inflammatory diseases (IMID), for example, RA, IBD or psoriasis, are at expanded danger of contamination, in part in light of the ailment itself, yet for the most part on account of treatment with immune-modulatory or immunosuppressive drugs. Regardless of their raised hazard for vaccine-preventable disease, immunization inclusion in IMID patients is surprisingly low. Despite the fact that the decreased nature of the resistant reaction in patients under immunotherapy negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for <span background-attachment:="" background-clip:="" background-origin:="" background-position:="" background-repeat:="" background-size:="" hepatitis="" span="" style="" background-image:"="">Influenza and Pneumococcal vaccination Innate immunity and diabetes vaccines


  • Vaccines for immunodeficiency diseases
  • Vaccination strategy in patients with IMID
  • Vaccinations in patients with immune-mediated inflammatory diseases
  • Central nervous system-targeted & Tissue-specific autoimmunity
  • Vaccines for autoimmune skin disorders & neuropathies
  • Vaccine safety: impact on disease activity in IMID patients

Related Conference of Vaccines for Immune Mediated Diseases

November 25-26, 2019

2nd World Heart Rhythm Conference

MENA Plaza Hotel Albarsha Dubai, UAE

Vaccines for Immune Mediated Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in